Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
HLS Therapeutics Inc
HLSCurrent price
3.37 CAD
-0.18 CAD (-5.07%)
Last closed
3.46 CAD
Company
www.hlstherapeutics.com
ISIN
CA40390B1094
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
Toronto Exchange
Capitalization
116 815 552 CAD
Yield for 12 month
-9.65 %
1Y
3Y
5Y
10Y
15Y
HLS
HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; and Vascepa, an icosapent ethyl capsules for cardiovascular disease. It also distributes MyCare psychiatry lab assays; and MyCare Insite, a point-of-care device to measure patient drug levels. In addition, the company holds the Canadian rights of Trinomia, a cardiovascular therapeutic; and a portfolio of royalty interests of four healthcare products. HLS Therapeutics Inc. is headquartered in Etobicoke, Canada. Address: 10 Carlson Court, Etobicoke, ON, Canada, M9W 6L2
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
7.48 CADP/E ratio
–Dividend Yield
–Current Year
+88 395 688 CAD
Last Year
+86 143 542 CAD
Current Quarter
+20 347 798 CAD
Last Quarter
+17 480 411 CAD
Current Year
+77 710 957 CAD
Last Year
+79 162 870 CAD
Current Quarter
+17 120 235 CAD
Last Quarter
+14 994 221 CAD
Key Figures HLS
1 year
3 years
5 years
10 years
EBITDA
17 418 982 CAD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-2.89 %
PEG Ratio
–
Return On Equity TTM
-24.82 %
Wall Street Target Price
7.48 CAD
Revenue TTM
59 283 328 CAD
Book Value
3.08 CAD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-11.6 %
Dividend Yield
–
Gross Profit TTM
51 096 285 CAD
Earnings per share
-0.97 CAD
Diluted Eps TTM
-0.97 CAD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-40.91 %
Dividend Analytics HLS
Dividend growth over 5 years
100 %Continuous growth
–Payout Ratio 5 years average
-31 %Dividend History HLS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
27.04.2023
Forward Annual Dividend Yield
–
Last Split Factor
1:5
Payout Ratio
–
Last Split Date
26.10.2006
Dividend Date
15.06.2023
Stock Valuation HLS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
185.1852
Enterprise Value Revenue
2.3666
Price Sales TTM
1.9705
Enterprise Value EBITDA
8.0417
Price Book MRQ
1.0548
Financials HLS
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators HLS
For 52 weeks
3.02 CAD
5.52 CAD
50 Day MA
3.55 CAD
Shares Short Prior Month
5 355
200 Day MA
3.82 CAD
Short Ratio
0.08
Shares Short
4 696
Short Percent
1.26 %
BeatStart